{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T14:05:10Z","timestamp":1794578710457,"version":"4.9.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T00:00:00Z","timestamp":1645488000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T00:00:00Z","timestamp":1645488000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The world-wide increase in chronic liver disease (CLD) calls for refinement of diagnostic and prognostic measures for early and accurate disease detection and management. Regardless of the aetiology, liver biopsy allows direct visualisation of specimen under the microscope. It facilitates histological evaluation of disease-specific morphological alterations. Thereby, it aids in disease diagnosis, prognosis, and assessment of treatment compliance\/response. Indeed, with the advent of non-invasive methods, liver biopsy is used less frequently than before, but it is still considered as a gold standard for staging and grading several CLDs. This short review revisits liver biopsy. It highlights the significance of liver biopsy in evaluating CLDs and explains the commonly used Ishak, METAVIR and Batts-Ludwig scoring systems for grading and staging CLDs. The utility of liver biopsy in examining alcohol-related liver disease and non-alcoholic fatty liver disease (NAFLD) is discussed along with the disease-specific alcoholic hepatitis histology score (AHHS) and non-alcoholic fatty liver disease activity score (NAS). Additionally, the review elaborates on the role of liver biopsy in evaluating viral hepatitis, haemochromatosis, and hepatocellular carcinoma. Contextual explanation on the diagnosis of metabolic dysfunction-associated liver disease (MAFLD) is provided. The significance and clinical indications of repeat biopsy are also explained. Lastly, caveats and limitations associated with liver biopsy are reviewed. Essentially, this review collates the application of liver biopsy in assessing various CLDs and provides succinct explanations of the core scoring systems, all under one roof. It is clinically relevant and provides a useful synopsis to budding scientists and hepato-pathologists.<\/jats:p>","DOI":"10.1007\/s10238-022-00799-z","type":"journal-article","created":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T05:02:59Z","timestamp":1645506179000},"page":"273-285","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":230,"title":["Liver biopsy for assessment of chronic liver diseases: a synopsis"],"prefix":"10.1007","volume":"23","author":[{"given":"Aqib B.","family":"Chowdhury","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0716-5081","authenticated-orcid":false,"given":"Kosha J.","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,22]]},"reference":[{"key":"799_CR1","doi-asserted-by":"crossref","unstructured":"Cheemerla S, Balakrishnan M. Global Epidemiology of Chronic Liver Disease. Clinical Liver Disease [Internet]. 2021 [cited 2021 Jul 19];17:365\u201370. Available from: https:\/\/aasldpubs.onlinelibrary.wiley.com\/doi\/abs\/10.1002\/cld.1061.","DOI":"10.1002\/cld.1061"},{"key":"799_CR2","doi-asserted-by":"crossref","unstructured":"Mehta KJ, Farnaud SJ, Sharp PA. Iron and liver fibrosis: Mechanistic and clinical aspects. World J Gastroenterol [Internet]. 2019 [cited 2019 Feb 28];25:521\u201338. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6371002\/.","DOI":"10.3748\/wjg.v25.i5.521"},{"key":"799_CR3","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","volume":"70","author":"SK Asrani","year":"2019","unstructured":"Asrani SK, Devarbhavi H, Eaton J, et al. Burden of liver diseases in the world. J Hepatol Elsevier. 2019;70:151\u201371.","journal-title":"J Hepatol Elsevier"},{"key":"799_CR4","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S2468-1253(19)30349-8","volume":"5","author":"SG Sepanlou","year":"2020","unstructured":"Sepanlou SG, Safiri S, Bisignano C, et al. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol Elsevier. 2020;5:245\u201366.","journal-title":"Lancet Gastroenterol Hepatol Elsevier"},{"key":"799_CR5","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1001\/jama.2015.5370","volume":"313","author":"ME Rinella","year":"2015","unstructured":"Rinella ME. Nonalcoholic fatty liver disease: a systematic review. JAMA. 2015;313:2263\u201373.","journal-title":"JAMA"},{"key":"799_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1055\/s-0036-1597816","volume":"37","author":"L Campana","year":"2017","unstructured":"Campana L, Iredale JP. Regression of liver fibrosis. Semin Liver Dis. 2017;37:1\u201310.","journal-title":"Semin Liver Dis"},{"key":"799_CR7","doi-asserted-by":"crossref","unstructured":"Berger D, Desai V, Janardhan S. Con: Liver Biopsy Remains the Gold Standard to Evaluate Fibrosis in Patients With Nonalcoholic Fatty Liver Disease. Clinical Liver Disease [Internet]. 2019 [cited 2021 Jul 31];13:114\u20136. Available from: https:\/\/aasldpubs.onlinelibrary.wiley.com\/doi\/abs\/10.1002\/cld.740.","DOI":"10.1002\/cld.740"},{"key":"799_CR8","doi-asserted-by":"crossref","unstructured":"Boyd A, Cain O, Chauhan A, et al. Medical liver biopsy: background, indications, procedure and histopathology. Frontline Gastroenterology [Internet]. British Medical Journal Publishing Group; 2020 [cited 2021 Sep 9];11:40\u20137. Available from: https:\/\/fg.bmj.com\/content\/11\/1\/40.","DOI":"10.1136\/flgastro-2018-101139"},{"key":"799_CR9","doi-asserted-by":"crossref","unstructured":"Sharma S, Khalili K, Nguyen GC. Non-invasive diagnosis of advanced fibrosis and cirrhosis. World J Gastroenterol [Internet]. 2014 [cited 2021 Sep 9];20:16820\u201330. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4258552\/.","DOI":"10.3748\/wjg.v20.i45.16820"},{"key":"799_CR10","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.jhep.2007.07.006","volume":"47","author":"ZD Goodman","year":"2007","unstructured":"Goodman ZD. Grading and staging systems for inflammation and fibrosis in chronic liver diseases. J Hepatol. 2007;47:598\u2013607.","journal-title":"J Hepatol"},{"key":"799_CR11","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1002\/hep.22742","volume":"49","author":"DC Rockey","year":"2009","unstructured":"Rockey DC, Caldwell SH, Goodman ZD, et al. Liver biopsy. Hepatology. 2009;49:1017\u201344.","journal-title":"Hepatology"},{"key":"799_CR12","unstructured":"Pandey N, Hoilat GJ, John S. Liver Biopsy. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 [cited 2021 Jan 23]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK470567\/."},{"key":"799_CR13","doi-asserted-by":"crossref","unstructured":"Washington K, Manns MP. 8 - Autoimmune Hepatitis. In: Burt AD, Ferrell LD, H\u00fcbscher SG, editors. Macsween\u2019s Pathology of the Liver (Seventh Edition) [Internet]. Elsevier; 2018 [cited 2021 Sep 9]. p. 491\u2013514. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/B978070206697900008X.","DOI":"10.1016\/B978-0-7020-6697-9.00008-X"},{"key":"799_CR14","doi-asserted-by":"crossref","unstructured":"Mani H, Kleiner DE. Liver biopsy findings in chronic hepatitis B. Hepatology [Internet]. 2009 [cited 2021 Sep 9];49:S61\u201371. Available from: https:\/\/aasldpubs.onlinelibrary.wiley.com\/doi\/abs\/10.1002\/hep.22930.","DOI":"10.1002\/hep.22930"},{"key":"799_CR15","unstructured":"Gill US, Pallett LJ, Kennedy PTF, et al. Liver sampling: a vital window into HBV pathogenesis on the path to functional cure. Gut [Internet]. BMJ Publishing Group; 2018 [cited 2021 Sep 21];67:767\u201375. Available from: https:\/\/gut.bmj.com\/content\/67\/4\/767."},{"key":"799_CR16","first-page":"1382","volume":"69","author":"J Neuberger","year":"2020","unstructured":"Neuberger J, Patel J, Caldwell H, et al. Guidelines on the use of liver biopsy in clinical practice from the British Society of Gastroenterology, the Royal College of Radiologists and the Royal College of Pathology. Gut BMJ Publishing Group. 2020;69:1382\u2013403.","journal-title":"Gut BMJ Publishing Group"},{"key":"799_CR17","first-page":"9026","volume":"20","author":"ILK Nalbantoglu","year":"2014","unstructured":"Nalbantoglu ILK, Brunt EM. Role of liver biopsy in nonalcoholic fatty liver disease. World J Gastroenterol. 2014;20:9026\u201337.","journal-title":"World J Gastroenterol"},{"key":"799_CR18","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1097\/00000478-199512000-00007","volume":"19","author":"KP Batts","year":"1995","unstructured":"Batts KP, Ludwig J. Chronic hepatitis. An update on terminology and reporting. Am J Surg Pathol. 1995;19:1409\u201317.","journal-title":"Am J Surg Pathol"},{"key":"799_CR19","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/hep.510240201","volume":"24","author":"P Bedossa","year":"1996","unstructured":"Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology. 1996;24:289\u201393.","journal-title":"Hepatology"},{"key":"799_CR20","doi-asserted-by":"crossref","unstructured":"Theise ND. Liver biopsy assessment in chronic viral hepatitis: a personal, practical approach. Mod Pathol [Internet]. 2007 [cited 2021 Sep 9];20:S3\u201314. Available from: https:\/\/www.nature.com\/articles\/3800693.","DOI":"10.1038\/modpathol.3800693"},{"key":"799_CR21","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/cld.653","volume":"10","author":"M Krishna","year":"2017","unstructured":"Krishna M. Patterns of necrosis in liver disease. Clin Liver Dis. 2017;10:53\u20136.","journal-title":"Clin Liver Dis"},{"key":"799_CR22","doi-asserted-by":"crossref","unstructured":"Butler DC, Lewin DN, Batalis NI. Differential Diagnosis of Hepatic Necrosis Encountered at Autopsy. Acad Forensic Pathol [Internet]. 2018 [cited 2021 Jul 31];8:256\u201395. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6490132\/.","DOI":"10.1177\/1925362118782056"},{"key":"799_CR23","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","volume":"22","author":"K Ishak","year":"1995","unstructured":"Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol. 1995;22:696\u20139.","journal-title":"J Hepatol"},{"key":"799_CR24","doi-asserted-by":"publisher","first-page":"276","DOI":"10.11613\/BM.2012.031","volume":"22","author":"ML McHugh","year":"2012","unstructured":"McHugh ML. Interrater reliability: the kappa statistic. Biochem Med (Zagreb). 2012;22:276\u201382.","journal-title":"Biochem Med (Zagreb)"},{"key":"799_CR25","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S0168-8278(02)00357-4","volume":"38","author":"R Rozario","year":"2003","unstructured":"Rozario R, Ramakrishna B. Histopathological study of chronic hepatitis B and C: a comparison of two scoring systems. J Hepatol. 2003;38:223\u20139.","journal-title":"J Hepatol"},{"key":"799_CR26","doi-asserted-by":"crossref","unstructured":"Crabb DW, Im GY, Szabo G, et al. Diagnosis and Treatment of Alcohol-Associated Liver Diseases: 2019 Practice Guidance From the American Association for the Study of Liver Diseases. Hepatology [Internet]. 2020 [cited 2021 Aug 6];71:306\u201333. Available from: https:\/\/aasldpubs.onlinelibrary.wiley.com\/doi\/abs\/10.1002\/hep.30866.","DOI":"10.1002\/hep.30866"},{"key":"799_CR27","doi-asserted-by":"publisher","first-page":"11684","DOI":"10.3748\/wjg.v20.i33.11684","volume":"20","author":"C Torruellas","year":"2014","unstructured":"Torruellas C, French SW, Medici V. Diagnosis of alcoholic liver disease. World J Gastroenterol. 2014;20:11684\u201399.","journal-title":"World J Gastroenterol"},{"key":"799_CR28","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2174\/1574887111666160724184103","volume":"11","author":"N Kobyliak","year":"2016","unstructured":"Kobyliak N, Dynnyk O, Abenavoli L. The role of liver biopsy to assess alcoholic liver disease. Rev Recent Clin Trials. 2016;11:175\u20139.","journal-title":"Rev Recent Clin Trials"},{"key":"799_CR29","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1053\/j.gastro.2014.01.018","volume":"146","author":"J Altamirano","year":"2014","unstructured":"Altamirano J, Miquel R, Katoonizadeh A, et al. A histologic scoring system for prognosis of patients with alcoholic hepatitis. Gastroenterology. 2014;146:1231-1239.e6.","journal-title":"Gastroenterology"},{"key":"799_CR30","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1177\/2050640620949737","volume":"8","author":"M Dubois","year":"2020","unstructured":"Dubois M, Sciarra A, Tr\u00e9po E, et al. Histologic parameter score does not predict short-term survival in severe alcoholic hepatitis. United Eur Gastroenterol J. 2020;8:1003\u201312.","journal-title":"United Eur Gastroenterol J"},{"key":"799_CR31","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American association for the study of liver diseases. Hepatology. 2018;67:328\u201357.","journal-title":"Hepatology"},{"key":"799_CR32","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1001\/jama.2020.2298","volume":"323","author":"AC Sheka","year":"2020","unstructured":"Sheka AC, Adeyi O, Thompson J, et al. Nonalcoholic steatohepatitis: a review. JAMA. 2020;323:1175\u201383.","journal-title":"JAMA"},{"key":"799_CR33","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1111\/j.1572-0241.1999.01377.x","volume":"94","author":"EM Brunt","year":"1999","unstructured":"Brunt EM, Janney CG, Di Bisceglie AM, et al. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol. 1999;94:2467\u201374.","journal-title":"Am J Gastroenterol"},{"key":"799_CR34","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41:1313\u201321.","journal-title":"Hepatology"},{"key":"799_CR35","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1002\/hep.24127","volume":"53","author":"EM Brunt","year":"2011","unstructured":"Brunt EM, Kleiner DE, Wilson LA, et al. The NAS and The histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings. Hepatology. 2011;53:810\u201320.","journal-title":"Hepatology"},{"key":"799_CR36","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"15","author":"Z Younossi","year":"2018","unstructured":"Younossi Z, Anstee QM, Marietti M, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2018;15:11\u201320.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"799_CR37","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","volume":"62","author":"CD Byrne","year":"2015","unstructured":"Byrne CD, Targher G. NAFLD: a multisystem disease. J Hepatol. 2015;62:S47-64.","journal-title":"J Hepatol"},{"key":"799_CR38","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1586\/17474124.2015.1074860","volume":"9","author":"L Miele","year":"2015","unstructured":"Miele L, Targher G. Understanding the association between developing a fatty liver and subsequent cardio-metabolic complications. Expert Rev Gastroenterol Hepatol. 2015;9:1243\u20135.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"799_CR39","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","volume":"73","author":"M Eslam","year":"2020","unstructured":"Eslam M, Newsome PN, Sarin SK, et al. A new definition for metabolic dysfunction-associated fatty liver disease: AN international expert consensus statement. J Hepatol Elsevier. 2020;73:202\u20139.","journal-title":"J Hepatol Elsevier"},{"key":"799_CR40","doi-asserted-by":"crossref","unstructured":"Godoy-Matos AF, Silva J\u00fanior WS, Valerio CM. NAFLD as a continuum: from obesity to metabolic syndrome and diabetes. Diabetol Metab Syndr [Internet]. 2020 [cited 2022 Jan 16];12:60. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7359287\/.","DOI":"10.1186\/s13098-020-00570-y"},{"key":"799_CR41","doi-asserted-by":"crossref","unstructured":"Tilg H, Effenberger M. From NAFLD to MAFLD: when pathophysiology succeeds. Nat Rev Gastroenterol Hepatol [Internet]. 2020 [cited 2022 Jan 15];17:387\u20138. Available from: https:\/\/www.nature.com\/articles\/s41575-020-0316-6.","DOI":"10.1038\/s41575-020-0316-6"},{"key":"799_CR42","doi-asserted-by":"crossref","unstructured":"De A, Ahmad N, Mehta M, et al. NAFLD vs. MAFLD \u2013 It is not the name but the disease that decides the outcome in fatty liver. Journal of Hepatology [Internet]. Elsevier; 2022 [cited 2022 Jan 15];76:475\u20137. Available from: https:\/\/www.journal-of-hepatology.eu\/article\/S0168-8278(21)02032-8\/fulltext.","DOI":"10.1016\/j.jhep.2021.09.002"},{"key":"799_CR43","doi-asserted-by":"crossref","unstructured":"Lin S, Huang J, Wang M, et al. Comparison of MAFLD and NAFLD diagnostic criteria in real world. Liver International [Internet]. 2020 [cited 2022 Jan 15];40:2082\u20139. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/abs\/10.1111\/liv.14548.","DOI":"10.1111\/liv.14548"},{"key":"799_CR44","unstructured":"European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu, European Association for the Study of the Liver. EASL Recommendations on Treatment of Hepatitis C 2018. J Hepatol. 2018;69:461\u2013511."},{"key":"799_CR45","unstructured":"European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu, European Association for the Study of the Liver. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol. 2017;67:370\u201398."},{"key":"799_CR46","doi-asserted-by":"crossref","unstructured":"Misdraji J. Changing indications for liver biopsy: viral hepatitis. Diagnostic Histopathology [Internet]. Elsevier; 2014 [cited 2021 Sep 21];20:119\u201324. Available from: https:\/\/www.diagnostichistopathology.co.uk\/article\/S1756-2317(14)00033-4\/abstract.","DOI":"10.1016\/j.mpdhp.2014.01.010"},{"key":"799_CR47","doi-asserted-by":"crossref","unstructured":"Pokorska-\u015apiewak M, Kowalik-Miko\u0142ajewska B, Aniszewska M, et al. Is liver biopsy still needed in children with chronic viral hepatitis? World J Gastroenterol [Internet]. 2015 [cited 2021 Sep 21];21:12141\u20139. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4641131\/.","DOI":"10.3748\/wjg.v21.i42.12141"},{"key":"799_CR48","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1053\/j.gastro.2015.06.045","volume":"149","author":"A Pietrangelo","year":"2015","unstructured":"Pietrangelo A. Genetics, genetic testing, and management of hemochromatosis: 15 years since hepcidin. Gastroenterology. 2015;149:1240-1251.e4.","journal-title":"Gastroenterology"},{"key":"799_CR49","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.24330","volume":"54","author":"BR Bacon","year":"2011","unstructured":"Bacon BR, Adams PC, Kowdley KV, et al. Diagnosis and management of hemochromatosis: 2011 practice guideline by the American association for the study of liver diseases. Hepatology. 2011;54:328\u201343.","journal-title":"Hepatology"},{"key":"799_CR50","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/bjh.15164","volume":"181","author":"EJ Fitzsimons","year":"2018","unstructured":"Fitzsimons EJ, Cullis JO, Thomas DW, et al. Diagnosis and therapy of genetic haemochromatosis (review and 2017 update). Br J Haematol. 2018;181:293\u2013303.","journal-title":"Br J Haematol"},{"key":"799_CR51","doi-asserted-by":"crossref","unstructured":"Kowdley KV, Brown KE, Ahn J, et al. ACG Clinical Guideline: Hereditary Hemochromatosis. Official journal of the American College of Gastroenterology | ACG [Internet]. 2019 [cited 2021 Sep 12];114:1202\u201318. Available from: https:\/\/journals.lww.com\/ajg\/Fulltext\/2019\/08000\/ACG_Clinical_Guideline__Hereditary_Hemochromatosis.11.aspx.","DOI":"10.14309\/ajg.0000000000000315"},{"key":"799_CR52","doi-asserted-by":"crossref","unstructured":"Tarao K, Nozaki A, Ikeda T, et al. Real impact of liver cirrhosis on the development of hepatocellular carcinoma in various liver diseases\u2014meta\u2010analytic assessment. Cancer Med [Internet]. 2019 [cited 2021 Sep 12];8:1054\u201365. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6434205\/.","DOI":"10.1002\/cam4.1998"},{"key":"799_CR53","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1097\/PAT.0b013e3283490e04","volume":"43","author":"ML Bassett","year":"2011","unstructured":"Bassett ML, Hickman PE, Dahlstrom JE. The changing role of liver biopsy in diagnosis and management of haemochromatosis. Pathology. 2011;43:433\u20139.","journal-title":"Pathology"},{"key":"799_CR54","doi-asserted-by":"crossref","unstructured":"Di Tommaso L, Spadaccini M, Donadon M, et al. Role of liver biopsy in hepatocellular carcinoma. World J Gastroenterol [Internet]. 2019 [cited 2021 Sep 12];25:6041\u201352. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6824282\/.","DOI":"10.3748\/wjg.v25.i40.6041"},{"key":"799_CR55","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1136\/gut.2008.149062","volume":"57","author":"MA Silva","year":"2008","unstructured":"Silva MA, Hegab B, Hyde C, et al. Needle track seeding following biopsy of liver lesions in the diagnosis of hepatocellular cancer: a systematic review and meta-analysis. Gut. 2008;57:1592\u20136.","journal-title":"Gut"},{"key":"799_CR56","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.jhep.2011.09.024","volume":"56","author":"EL Ellis","year":"2012","unstructured":"Ellis EL, Mann DA. Clinical evidence for the regression of liver fibrosis. J Hepatol. 2012;56:1171\u201380.","journal-title":"J Hepatol"},{"key":"799_CR57","doi-asserted-by":"crossref","unstructured":"Mathew S, Narang R, Pericleous M, et al. PWE-117 The role of repeat liver biopsies in autoimmune hepatitis: clinical practice and outcomes. Gut [Internet]. BMJ Publishing Group; 2015 [cited 2022 Jan 13];64:A263\u20134. Available from: https:\/\/gut.bmj.com\/content\/64\/suppl_1\/a263.3.","DOI":"10.1136\/gutjnl-2015-309861.566"},{"key":"799_CR58","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.pathol.2016.05.001","volume":"48","author":"J Putra","year":"2016","unstructured":"Putra J, Toor A, Suriawinata AA. The utility of repeat liver biopsy in autoimmune hepatitis: a series of 20 consecutive cases. Pathology. 2016;48:449\u201353.","journal-title":"Pathology"},{"key":"799_CR59","doi-asserted-by":"crossref","unstructured":"Mohan P, Barton BA, Narkewicz MR, et al. Evaluating progression of liver disease from repeat liver biopsies in children with chronic hepatitis C- a retrospective study. Hepatology [Internet]. 2013 [cited 2022 Jan 13];58:1580\u20136. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5493995\/.","DOI":"10.1002\/hep.26519"},{"key":"799_CR60","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s00270-001-0123-6","volume":"25","author":"E Caturelli","year":"2002","unstructured":"Caturelli E, Biasini E, Bartolucci F, et al. Diagnosis of hepatocellular carcinoma complicating liver cirrhosis: utility of repeat ultrasound-guided biopsy after unsuccessful first sampling. Cardiovasc Intervent Radiol. 2002;25:295\u20139.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"799_CR61","first-page":"820","volume":"40","author":"E Fassio","year":"2004","unstructured":"Fassio E, Alvarez E, Dom\u00ednguez N, et al. Natural history of nonalcoholic steatohepatitis: a longitudinal study of repeat liver biopsies. Hepatology. 2004;40:820\u20136.","journal-title":"Hepatology"},{"key":"799_CR62","doi-asserted-by":"crossref","unstructured":"Lefkowitch JH. Chapter 1 - General Principles of Biopsy Assessment. In: Lefkowitch JH, editor. Scheuer\u2019s Liver Biopsy Interpretation (Tenth Edition) [Internet]. London: Elsevier; 2021. p. 1\u201312. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/B9780702075841000012.","DOI":"10.1016\/B978-0-7020-7584-1.00001-2"},{"key":"799_CR63","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1155\/2013\/429834","volume":"27","author":"M Aljawad","year":"2013","unstructured":"Aljawad M, Yoshida EM, Uhanova J, et al. Percutaneous liver biopsy practice patterns among Canadian hepatologists. Can J Gastroenterol. 2013;27:e31\u20134.","journal-title":"Can J Gastroenterol"},{"key":"799_CR64","doi-asserted-by":"publisher","first-page":"5772","DOI":"10.1007\/s00330-019-06227-3","volume":"29","author":"A Maheux","year":"2019","unstructured":"Maheux A, Purcell Y, Harguem S, et al. Targeted and non-targeted liver biopsies carry the same risk of complication. Eur Radiol. 2019;29:5772\u201383.","journal-title":"Eur Radiol"},{"key":"799_CR65","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1053\/j.gastro.2005.03.084","volume":"128","author":"V Ratziu","year":"2005","unstructured":"Ratziu V, Charlotte F, Heurtier A, et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology. 2005;128:1898\u2013906.","journal-title":"Gastroenterology"},{"key":"799_CR66","doi-asserted-by":"publisher","first-page":"2614","DOI":"10.1111\/j.1572-0241.2002.06038.x","volume":"97","author":"A Regev","year":"2002","unstructured":"Regev A, Berho M, Jeffers LJ, et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol. 2002;97:2614\u20138.","journal-title":"Am J Gastroenterol"},{"key":"799_CR67","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/hep.20535","volume":"41","author":"M-C Rousselet","year":"2005","unstructured":"Rousselet M-C, Michalak S, Dupr\u00e9 F, et al. Sources of variability in histological scoring of chronic viral hepatitis. Hepatology. 2005;41:257\u201364.","journal-title":"Hepatology"},{"key":"799_CR68","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1111\/acer.13438","volume":"41","author":"B Horvath","year":"2017","unstructured":"Horvath B, Allende D, Xie H, et al. Interobserver variability in scoring liver biopsies with a diagnosis of alcoholic hepatitis. Alcohol Clin Exp Res. 2017;41:1568\u201373.","journal-title":"Alcohol Clin Exp Res"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-022-00799-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-022-00799-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-022-00799-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T12:07:58Z","timestamp":1685189278000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-022-00799-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,22]]},"references-count":68,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,6]]}},"alternative-id":["799"],"URL":"https:\/\/doi.org\/10.1007\/s10238-022-00799-z","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,22]]},"assertion":[{"value":"30 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This manuscript is a review article and does not involve a research protocol requiring approval by the relevant institutional review board or ethics committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}